Text Size

Increased anterior chamber penetration of topical levofloxacin 0.5% after pulsed dosing in cataract patients

Sundelin K., Seal D., Gardner S., Ropo A., Geldsetzer K., Lokkila J., Stenevi U.


  • 2009
  • Acta Ophthalmologica
View publication
  • Therapeutic Area

    Other

  • Categories

    Clinical development

  • Affiliations

    Department of Ophthalmology, Sahlgrenska University Hospital/Mölndal, SE-431 80 Mölndal, Sweden; Department of Ophthalmology, Sahlgrenska University Hospital, Mölndal, Sweden; Applied Vision Research Centre, City University, London, United Kingdom; OTM Inc., Atlanta, GA, United States; Santen Oy, Tampere, Finland; Department of Research and Development, Santen GmbH, Germering, Germany; Laboratory Center, Santen Oy, Tampere, Finland

Related Publications

Viability of European cross-border access opportunities to streamline access to ATMPs

Angelillo L.; van Steen C.; Ross-Stewart K.; Dehnen J.; Colasante W.


Influence of BAKs on Tear Film Lipid Layer: in vitro and in silico models

Riedlová K., Saija M.C., Olżyńska A., Jurkiewicz P., Daull P., Garrigue J.-S., Cwiklik L.


How Useful Are Digital Health Terms for Outcomes Research? An ISPOR Special Interest Group Report

Burrell, Anita; Zrubka, Zsombor; Champion, Annette; Zah, Vladimir; Vinuesa, Laura; Holtorf, Anke-Peggy; Di Bidino, Rosella; Earla, Jagadeswara Rao; Entwistle, Joanna; Boltyenkov, Artem Tarasovic; Braileanu, George; Kolasa, Katarzyna; Roydhouse, Jessica; Asche, Carl


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022